Prostate Cancer Adjunct Therapies

Prostate cancer surgery adjunct therapies include external beam radiation, and chemo therapy with many other modalities in clinical research trials. Adjunct treatment is given along with the main prostate cancer surgery procedure to help ensure a positive outcome for men combating prostate cancer.

Prostate cancer surgery adjunct therapies are part of the treatment plans created at our comprehensive Urology Specialists center. Along with working with your primary doctor and any specialists that you are seeing, we also are involved in clinical research trials for prostate cancer. We will constantly investigate and offer to our clients the available emerging medical procedures and care plans for prostate cancer prevention, prostate cancer diagnostics, prostate cancer treatments, prostate cancer pain management, and prostate cancer recovery. Our approach is comprehensive because cancer is different for everyone, every individual’s overall health varies, everybody has a different genetic make-up, and each person has their own values. Whether you what a natural medicine holistic procedure approach, minimally invasive approach, radical prostatectomy, translational medicine, or a watchful waiting approach we will help explain your best options, according to your specific circumstances.
Modern medicine is using more of a combined treatment strategy as more information comes in about the molecular and cellular mechanisms of action involved in the cancer process, the treatment process and the healing process. These mechanisms of action occur from:

• Different prostate cancers, the most common being adenocarcinoma
• The different locations of the cancer, in the prostate and outside of the prostate
• The different prostate cancer surgery procedures, prostate removal, cryosurgical, prostate radiation seeds all affect our body differently
• Differences in personal genomes, currently exome biomarker genomes are commercially available and inexpensive, by 2013 complete personal genomes will be both commercially and economically available to become widespread in diagnosing and planning treatments.
• Epigenetic alteration, by methylated DNA is easily influenced by its environment and is now being tracked and studied so that we can understand what is, and what causes, a bad cellular environment. Our goal is to eventually create cellular tools to produce positive protein production from affected methylated DNA.
• The cancer genome, the NIH has begun the Cancer Genome Atlas which tracks mutations, chromosomal copy number alterations and gene expression.
• Proteomics, show us what proteins are being produced by our ribosomes, which will allow us to monitor in real-time, our body’s ability to create needed enzymes and tissue, to rebuild our diseased or healing body.
• System wide cell signaling, cell signaling has been found to instigate or repair diseases that are seemingly not connected to another system, which is why cell signaling has become a large part of the biotech market and entering into translational medicine.

Prostate cancer surgery adjunct therapies are not always needed but follow-ups visits to track any untoward effects, and to monitor any chance of prostate cancer recurrence is necessary. We will schedule these follow-up visits before you leave after your prostate cancer surgery. If you live in another state or country you can be monitored by your local urologist and primary doctor.

<< Prostate Cancer Surgery Seed Implants | Prostate Cancer Surgery >>